Urine Lunx mRNA as a Potential Molecular Diagnostic Tool for Lung Cancer

Urine Lunx mRNA as a Potential Molecular Diagnostic Tool for Lung Cancer

Loading document ...
Page
of
Loading page ...

Author(s)

Author(s): Sanxia Zhao, Yinlin Ge

Download Full PDF Read Complete Article

DOI: 10.18483/ijSci.1782 80 290 1-3 Volume 7 - Sep 2018

Abstract

Objective: Exploring the expression of cell-free RNA in urine of normal patients and lung cancer patients, analyze its clinical value in the dignosis of lung cancer. Methods: The urine samples were collected from lung cancer patients and healthy people. Extracted the total cf-RNA from all samples. The contents of total cf-RNA in two groups were detected, and the expressions of LUNX mRNA in two groups were measured by quantitative real-time PCR. Receiver-operating characteristics (ROC) curve was established to evaluate the diagnostic value of urine cf-RNA for the differentiation between lung cancer patients and the control group. Results: Compare to the normal group (50.50±4.527ng), the urinary cf-RNA content in patients (133.8±8.615ng) was significantly increased, p<0.05. The expression of urinary lunx mRNA level from patients was raised, p<0.05. ROC curve analysis showed that, in the diagnosis, AUC value of lunx mRNA was 0.83(95% CI, 0.747-0.906), p<0.05. Conclusion: The expression of urine cf-RNA and Lunx mRNA was elevated, and can be used as a potential molecular diagnostic tool for lung cancer.

Keywords

Urine, Lung Cancer, cf-RNA, Diagnosis

References

  1. Xu-Welliver M, Carbone D P. Blood-based biomarkers in lung cancer: prognosis and treatment decisions[J]. Translational lung cancer research, 2017, 6(6): 708.
  2. Chen Y Q, Li D M, Cai Y Y, et al. The expression of survivin messenger RNA in sputum and cancerous tissue in human lung cancer [J]. CHINESE JOURNAL OF TUBERCULOSIS AND RESPIRATORY DISEASES, 2005, 28(4):225-229.
  3. Jing J, Gao Y H. Urine as a Source of Novel Biomarkers [J]. Progress in Biochemistry and Biophysics, 2016, 43(11): 1019-1028.
  4. Zhao A, Péoc'h M, Cottier M, et al. Cell‐free RNA content in urine as a possible molecular diagnostic tool for clear cell renal cell carcinoma[J]. International journal of cancer, 2015, 136(11): 2610-2615.
  5. Zhang F, Cheng X, Yuan Y, et al. Urinary microRNA can be concentrated, dried on membranes and stored at room temperature in vacuum bags[J]. PeerJ, 2015, 3: e1082.
  6. Zhao W J, Zhou H X, Wang S J et al. The clinical significance of Lunx mRNA detection in plasma and peripheral mononuclear cells in patients with lung cancer [J]. LABORATORY MEDICINE, 2012, 27(8):631-634.
  7. Kapellos G, Polonifi K, Farmakis D, et al. Overexpression of survivin levels in circulation and tissue samples of lung cancer patients[J]. Anticancer research, 2013, 33(8): 3475-3480.
  8. Zhao W, Zhao J J, Zhang L, et al. Serum miR-21 level: a potential diagnostic and prognostic biomarker for non-small cell lung cancer[J]. International journal of clinical and experimental medicine, 2015, 8(9): 14759.
  9. Kao H W, Pan C Y, Lai C H, et al. Urine miR-21-5p as a potential non-invasive biomarker for gastric cancer[J]. Oncotarget, 2017, 8(34): 56389.
  10. Wang C,Li Y,Fang X D. Research progress on liquid biopsy in oncology and its clinical applications. Hereditas(Beijing), 2017, 39(3): 220-231.

Cite this Article:

International Journal of Sciences is Open Access Journal.
This article is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) License.
Author(s) retain the copyrights of this article, though, publication rights are with Alkhaer Publications.

Search Articles

Issue June 2024

Volume 13, June 2024


Table of Contents



World-wide Delivery is FREE

Share this Issue with Friends:


Submit your Paper